I missed PFE at $13 per share. Now looking for GNBT, any idea?????
Should buy or not this stock??? Compare two competitors: GNBT and MNKD
Only one drug candidate, failed FDA approval at earlier this year
Company has two drug candidate:
one is Oral lyn (needless insulin, a competitor for MNKD). It is in the final step of phase III trial;
one is AE37 (A cancer vaccine), it just acomplished its phase II trial, ready for phase III trial.